Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Buy
76
ADMA Quote, Financials, Valuation and Earnings
Last price:
$19.80
Seasonality move
:
18.35%
Day range:
$19.17 - $19.82
52-week range:
$5.90 - $23.64
Dividend yield:
0%
P/E ratio:
24.15x
P/S ratio:
11.28x
P/B ratio:
13.48x
Volume:
8.6M
Avg. volume:
3M
1-year change:
219.87%
Market cap:
$4.7B
Revenue:
$426.5M
EPS (TTM):
$0.82
ADMA Analysts' Consensus Rating
The 4 analysts providing 12-month price projections for ADMA Biologics shares anticipate an average target of $25.27, ranging from a low estimate of $19.09 to a high estimate of $32.00. This average target implies a growth of 27.64% compared to the current stock price of $19.80.
Consensus Price Target
$25.27
Highest Price Target
$32.00
Lowest Price Target
$19.09
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 0 | 4 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | -- | -- | Buy |
ADMA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
